

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.10804872 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.79494795 |
| 3 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.51887007 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.51487955 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.38599268 |
| 6 | glutamate secretion (GO:0014047) | 4.29957899 |
| 7 | regulation of synaptic vesicle transport (GO:1902803) | 4.12899150 |
| 8 | presynaptic membrane assembly (GO:0097105) | 4.04537000 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.01087913 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.87524668 |
| 11 | locomotory exploration behavior (GO:0035641) | 3.83267638 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.82102184 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.81249328 |
| 14 | presynaptic membrane organization (GO:0097090) | 3.78603227 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.76512580 |
| 16 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.71747250 |
| 17 | neurotransmitter secretion (GO:0007269) | 3.70071848 |
| 18 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67786903 |
| 19 | establishment of nucleus localization (GO:0040023) | 3.66832289 |
| 20 | protein localization to synapse (GO:0035418) | 3.63816250 |
| 21 | vocalization behavior (GO:0071625) | 3.61916594 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 3.53211901 |
| 23 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.38757060 |
| 24 | postsynaptic membrane organization (GO:0001941) | 3.37102491 |
| 25 | inositol phosphate catabolic process (GO:0071545) | 3.36693036 |
| 26 | nucleobase catabolic process (GO:0046113) | 3.29979845 |
| 27 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.29853574 |
| 28 | neuron recognition (GO:0008038) | 3.29273583 |
| 29 | long-term synaptic potentiation (GO:0060291) | 3.28713326 |
| 30 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.24244994 |
| 31 | axonal fasciculation (GO:0007413) | 3.20677231 |
| 32 | proline transport (GO:0015824) | 3.16370251 |
| 33 | negative regulation of dendrite development (GO:2000171) | 3.15566817 |
| 34 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.14334715 |
| 35 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.12917722 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.11645146 |
| 37 | cell migration in hindbrain (GO:0021535) | 3.10928852 |
| 38 | regulation of cell communication by electrical coupling (GO:0010649) | 3.10162885 |
| 39 | synapse assembly (GO:0007416) | 3.10064258 |
| 40 | regulation of coenzyme metabolic process (GO:0051196) | 3.07782850 |
| 41 | regulation of cofactor metabolic process (GO:0051193) | 3.07782850 |
| 42 | nerve growth factor signaling pathway (GO:0038180) | 3.07413204 |
| 43 | establishment of mitochondrion localization (GO:0051654) | 3.03491526 |
| 44 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.01181357 |
| 45 | clathrin coat assembly (GO:0048268) | 3.00671280 |
| 46 | activation of protein kinase A activity (GO:0034199) | 2.97189671 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 2.94962512 |
| 48 | neuronal action potential propagation (GO:0019227) | 2.94951366 |
| 49 | exploration behavior (GO:0035640) | 2.94579675 |
| 50 | auditory behavior (GO:0031223) | 2.94406626 |
| 51 | oxaloacetate metabolic process (GO:0006107) | 2.91731094 |
| 52 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.89954031 |
| 53 | dendrite morphogenesis (GO:0048813) | 2.89828412 |
| 54 | layer formation in cerebral cortex (GO:0021819) | 2.84444731 |
| 55 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.83312570 |
| 56 | positive regulation of synapse maturation (GO:0090129) | 2.83078393 |
| 57 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.82426137 |
| 58 | innervation (GO:0060384) | 2.82414368 |
| 59 | positive regulation of synapse assembly (GO:0051965) | 2.78663363 |
| 60 | urinary tract smooth muscle contraction (GO:0014848) | 2.78054521 |
| 61 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.78010705 |
| 62 | neuron cell-cell adhesion (GO:0007158) | 2.76987996 |
| 63 | COPI coating of Golgi vesicle (GO:0048205) | 2.76955879 |
| 64 | Golgi transport vesicle coating (GO:0048200) | 2.76955879 |
| 65 | vesicle transport along microtubule (GO:0047496) | 2.76934509 |
| 66 | synaptic transmission, glutamatergic (GO:0035249) | 2.76827230 |
| 67 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.76474146 |
| 68 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.75819740 |
| 69 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.75118921 |
| 70 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.74200184 |
| 71 | signal complex assembly (GO:0007172) | 2.73119562 |
| 72 | membrane depolarization during action potential (GO:0086010) | 2.72601662 |
| 73 | succinate metabolic process (GO:0006105) | 2.70336911 |
| 74 | tricarboxylic acid cycle (GO:0006099) | 2.69183019 |
| 75 | synapse organization (GO:0050808) | 2.68162057 |
| 76 | long term synaptic depression (GO:0060292) | 2.68154045 |
| 77 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.66755161 |
| 78 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.65271856 |
| 79 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.64070731 |
| 80 | cell differentiation in hindbrain (GO:0021533) | 2.63568644 |
| 81 | lactate metabolic process (GO:0006089) | 2.62670799 |
| 82 | response to auditory stimulus (GO:0010996) | 2.62405554 |
| 83 | long-term memory (GO:0007616) | 2.62393940 |
| 84 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.61659813 |
| 85 | regulation of neurotransmitter secretion (GO:0046928) | 2.61619449 |
| 86 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.61258162 |
| 87 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.61258162 |
| 88 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.60825897 |
| 89 | cerebellar granule cell differentiation (GO:0021707) | 2.60231024 |
| 90 | regulation of synapse assembly (GO:0051963) | 2.58537370 |
| 91 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.58271078 |
| 92 | regulation of neurotransmitter levels (GO:0001505) | 2.57959486 |
| 93 | positive regulation of membrane potential (GO:0045838) | 2.57923138 |
| 94 | actin-myosin filament sliding (GO:0033275) | 2.57919016 |
| 95 | muscle filament sliding (GO:0030049) | 2.57919016 |
| 96 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.57382769 |
| 97 | neuron-neuron synaptic transmission (GO:0007270) | 2.56579623 |
| 98 | nucleus localization (GO:0051647) | 2.56341755 |
| 99 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.54825073 |
| 100 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.54656033 |
| 101 | regulation of neurotransmitter transport (GO:0051588) | 2.53356185 |
| 102 | neuromuscular synaptic transmission (GO:0007274) | 2.52801788 |
| 103 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.52597522 |
| 104 | cerebellar Purkinje cell layer development (GO:0021680) | 2.52517984 |
| 105 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.52441036 |
| 106 | neurotransmitter transport (GO:0006836) | 2.52302133 |
| 107 | cell communication by electrical coupling (GO:0010644) | 2.51708700 |
| 108 | inositol phosphate dephosphorylation (GO:0046855) | 2.51127259 |
| 109 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.51127259 |
| 110 | spinal cord association neuron differentiation (GO:0021527) | 2.50927511 |
| 111 | organelle transport along microtubule (GO:0072384) | 2.50818492 |
| 112 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.50682929 |
| 113 | muscle hypertrophy in response to stress (GO:0003299) | 2.50682929 |
| 114 | cardiac muscle adaptation (GO:0014887) | 2.50682929 |
| 115 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.50524869 |
| 116 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.50122385 |
| 117 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.48258498 |
| 118 | synaptic vesicle transport (GO:0048489) | 2.47476286 |
| 119 | establishment of synaptic vesicle localization (GO:0097480) | 2.47476286 |
| 120 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.47412974 |
| 121 | positive regulation of muscle hypertrophy (GO:0014742) | 2.47412974 |
| 122 | transferrin transport (GO:0033572) | 2.47387965 |
| 123 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.46734022 |
| 124 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.45384885 |
| 125 | regulation of relaxation of muscle (GO:1901077) | 2.44223032 |
| 126 | regulation of membrane repolarization (GO:0060306) | 2.43953861 |
| 127 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.43303004 |
| 128 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.42302583 |
| 129 | regulation of synaptic plasticity (GO:0048167) | 2.42081421 |
| 130 | regulation of sulfur metabolic process (GO:0042762) | 2.41838763 |
| 131 | cellular potassium ion homeostasis (GO:0030007) | 2.41726969 |
| 132 | regulation of glucocorticoid secretion (GO:2000849) | 2.40919779 |
| 133 | axon extension (GO:0048675) | 2.40795301 |
| 134 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.40783137 |
| 135 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.39599384 |
| 136 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.39513925 |
| 137 | regulation of respiratory system process (GO:0044065) | 2.38919655 |
| 138 | neuronal ion channel clustering (GO:0045161) | 2.38551521 |
| 139 | glutamate receptor signaling pathway (GO:0007215) | 2.38354407 |
| 140 | hippocampus development (GO:0021766) | 2.36598400 |
| 141 | regulation of dendritic spine development (GO:0060998) | 2.36551880 |
| 142 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.35755987 |
| 143 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.35672835 |
| 144 | regulation of postsynaptic membrane potential (GO:0060078) | 2.34544048 |
| 145 | synaptic vesicle endocytosis (GO:0048488) | 2.34181044 |
| 146 | positive regulation of dendritic spine development (GO:0060999) | 2.34092823 |
| 147 | axon ensheathment in central nervous system (GO:0032291) | 2.33475889 |
| 148 | central nervous system myelination (GO:0022010) | 2.33475889 |
| 149 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.32711740 |
| 150 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.32685773 |
| 151 | cellular sodium ion homeostasis (GO:0006883) | 2.32525434 |
| 152 | negative regulation of neurotransmitter transport (GO:0051589) | 2.29729524 |
| 153 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.28417146 |
| 154 | cardiac muscle contraction (GO:0060048) | 2.28364695 |
| 155 | regulation of synapse organization (GO:0050807) | 2.28243461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.91032081 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.00908435 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.90656082 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.71608795 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.58677103 |
| 6 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.26464621 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.20642480 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.16649094 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15588446 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.14372114 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.14308795 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13808648 |
| 13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.07628158 |
| 14 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.93159871 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.91698468 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.90744294 |
| 17 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.85407778 |
| 18 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.82431154 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80100173 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.79988132 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.79528371 |
| 22 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.76405011 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74079969 |
| 24 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73535980 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70996720 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70762838 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70762838 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70111907 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.68051732 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.64652308 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62622368 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.62107115 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.61690203 |
| 34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60668100 |
| 35 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.60664699 |
| 36 | AR_25329375_ChIP-Seq_VCAP_Human | 1.60018906 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.56836586 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.54948520 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54846405 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.54116756 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.53402633 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.51849601 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.51596884 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.49628791 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48507288 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44276980 |
| 47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.43807998 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40975040 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.39782544 |
| 50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38768121 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38735118 |
| 52 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38553226 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34853364 |
| 54 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.32600543 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32565377 |
| 56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31319745 |
| 57 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.31285818 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29892240 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28621293 |
| 60 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.28279891 |
| 61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28165446 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27687223 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.26818026 |
| 64 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.25716721 |
| 65 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25676335 |
| 66 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.25127929 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.24590535 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23597472 |
| 69 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.23421796 |
| 70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23341664 |
| 71 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21340896 |
| 72 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21039721 |
| 73 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21039721 |
| 74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21028195 |
| 75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21028195 |
| 76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.20976686 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20361197 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19243268 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18484851 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.18390837 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17950052 |
| 82 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17827653 |
| 83 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17428055 |
| 84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16941595 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16889409 |
| 86 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.15503600 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13350463 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11592799 |
| 89 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11202154 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09753311 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09121946 |
| 92 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.07955876 |
| 93 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07937320 |
| 94 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07858693 |
| 95 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07858693 |
| 96 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07803766 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06871696 |
| 98 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06798588 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06587637 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06001007 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05784331 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05317830 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05112017 |
| 104 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03458102 |
| 105 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03183383 |
| 106 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.01932731 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01839318 |
| 108 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01731778 |
| 109 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01708235 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01556498 |
| 111 | JUN_21703547_ChIP-Seq_K562_Human | 1.01106957 |
| 112 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00204068 |
| 113 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99913001 |
| 114 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99289524 |
| 115 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98918992 |
| 116 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98834059 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98180046 |
| 118 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98024182 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97657838 |
| 120 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97468753 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97088909 |
| 122 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.96125111 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95985876 |
| 124 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95131115 |
| 125 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94402851 |
| 126 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92432034 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91860636 |
| 128 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91251066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.26037071 |
| 2 | MP0004270_analgesia | 3.39412626 |
| 3 | MP0003880_abnormal_central_pattern | 3.37785821 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.28126314 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 2.98640020 |
| 6 | MP0003787_abnormal_imprinting | 2.93863256 |
| 7 | MP0002822_catalepsy | 2.79539203 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.77426989 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.40145561 |
| 10 | MP0009745_abnormal_behavioral_response | 2.35788513 |
| 11 | MP0002736_abnormal_nociception_after | 2.31925887 |
| 12 | MP0003879_abnormal_hair_cell | 2.24685305 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.23277095 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.18082139 |
| 15 | MP0000751_myopathy | 2.17981791 |
| 16 | MP0002064_seizures | 2.17215329 |
| 17 | MP0009046_muscle_twitch | 2.15826576 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.15546073 |
| 19 | MP0003646_muscle_fatigue | 2.11538220 |
| 20 | MP0004130_abnormal_muscle_cell | 2.01246440 |
| 21 | MP0008569_lethality_at_weaning | 1.98454606 |
| 22 | MP0003690_abnormal_glial_cell | 1.98216240 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 1.95301850 |
| 24 | MP0001502_abnormal_circadian_rhythm | 1.87974851 |
| 25 | MP0002272_abnormal_nervous_system | 1.84258557 |
| 26 | MP0002184_abnormal_innervation | 1.81730815 |
| 27 | MP0004142_abnormal_muscle_tone | 1.73411175 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.72417698 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.70933199 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.69993500 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.69908389 |
| 32 | MP0003724_increased_susceptibility_to | 1.64202009 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.59347701 |
| 34 | MP0002735_abnormal_chemical_nociception | 1.57173593 |
| 35 | MP0005423_abnormal_somatic_nervous | 1.54782648 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.52958102 |
| 37 | MP0004233_abnormal_muscle_weight | 1.51367320 |
| 38 | MP0001529_abnormal_vocalization | 1.49062954 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.47446242 |
| 40 | MP0000778_abnormal_nervous_system | 1.46179421 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.45155766 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.43517735 |
| 43 | MP0004885_abnormal_endolymph | 1.43138711 |
| 44 | MP0001486_abnormal_startle_reflex | 1.42048255 |
| 45 | MP0004084_abnormal_cardiac_muscle | 1.40229388 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.37168372 |
| 47 | MP0004924_abnormal_behavior | 1.37168372 |
| 48 | MP0004215_abnormal_myocardial_fiber | 1.35599935 |
| 49 | MP0005248_abnormal_Harderian_gland | 1.34705988 |
| 50 | MP0000955_abnormal_spinal_cord | 1.34074022 |
| 51 | MP0001299_abnormal_eye_distance/ | 1.31914551 |
| 52 | MP0004085_abnormal_heartbeat | 1.24207596 |
| 53 | MP0000920_abnormal_myelination | 1.21929991 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.21369381 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.20644617 |
| 56 | MP0004036_abnormal_muscle_relaxation | 1.20555073 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.20415339 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.20109941 |
| 59 | MP0000747_muscle_weakness | 1.19819190 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.19088319 |
| 61 | MP0003632_abnormal_nervous_system | 1.18256640 |
| 62 | MP0004484_altered_response_of | 1.17803111 |
| 63 | MP0005620_abnormal_muscle_contractility | 1.17426717 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.17274993 |
| 65 | MP0003329_amyloid_beta_deposits | 1.16974590 |
| 66 | MP0002882_abnormal_neuron_morphology | 1.15784753 |
| 67 | MP0003137_abnormal_impulse_conducting | 1.15704859 |
| 68 | MP0001984_abnormal_olfaction | 1.15383092 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.15215568 |
| 70 | MP0001970_abnormal_pain_threshold | 1.14884600 |
| 71 | MP0000749_muscle_degeneration | 1.14739633 |
| 72 | MP0003634_abnormal_glial_cell | 1.13284653 |
| 73 | MP0001849_ear_inflammation | 1.08635813 |
| 74 | MP0003633_abnormal_nervous_system | 1.08230131 |
| 75 | MP0003303_peritoneal_inflammation | 1.08016920 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.06974144 |
| 77 | MP0006054_spinal_hemorrhage | 1.06126950 |
| 78 | MP0005187_abnormal_penis_morphology | 1.05159975 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 1.05065650 |
| 80 | MP0000003_abnormal_adipose_tissue | 1.03682206 |
| 81 | MP0004858_abnormal_nervous_system | 1.03399162 |
| 82 | MP0001177_atelectasis | 1.02525982 |
| 83 | MP0002152_abnormal_brain_morphology | 1.02341396 |
| 84 | MP0003121_genomic_imprinting | 0.99798082 |
| 85 | MP0001905_abnormal_dopamine_level | 0.99291996 |
| 86 | MP0001958_emphysema | 0.98636183 |
| 87 | MP0001440_abnormal_grooming_behavior | 0.97649170 |
| 88 | MP0002876_abnormal_thyroid_physiology | 0.96278450 |
| 89 | MP0004510_myositis | 0.96040575 |
| 90 | MP0003122_maternal_imprinting | 0.95924181 |
| 91 | MP0008877_abnormal_DNA_methylation | 0.95850646 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92278550 |
| 93 | MP0002972_abnormal_cardiac_muscle | 0.91599213 |
| 94 | MP0003631_nervous_system_phenotype | 0.90767497 |
| 95 | MP0006138_congestive_heart_failure | 0.90484703 |
| 96 | MP0010368_abnormal_lymphatic_system | 0.88867740 |
| 97 | MP0000750_abnormal_muscle_regeneration | 0.88080352 |
| 98 | MP0002106_abnormal_muscle_physiology | 0.87038541 |
| 99 | MP0005171_absent_coat_pigmentation | 0.85710896 |
| 100 | MP0004742_abnormal_vestibular_system | 0.85105004 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.84735937 |
| 102 | MP0004087_abnormal_muscle_fiber | 0.83856975 |
| 103 | MP0002752_abnormal_somatic_nervous | 0.83704794 |
| 104 | MP0000759_abnormal_skeletal_muscle | 0.82760168 |
| 105 | MP0005535_abnormal_body_temperature | 0.82711508 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.82022375 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.79912134 |
| 108 | MP0002127_abnormal_cardiovascular_syste | 0.78955972 |
| 109 | MP0001188_hyperpigmentation | 0.78875164 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.76295487 |
| 111 | MP0002069_abnormal_eating/drinking_beha | 0.76222027 |
| 112 | MP0005369_muscle_phenotype | 0.74449474 |
| 113 | MP0002108_abnormal_muscle_morphology | 0.73771901 |
| 114 | MP0002971_abnormal_brown_adipose | 0.73760635 |
| 115 | MP0005253_abnormal_eye_physiology | 0.72585090 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.72253840 |
| 117 | MP0004147_increased_porphyrin_level | 0.72185590 |
| 118 | MP0000026_abnormal_inner_ear | 0.72070972 |
| 119 | MP0002133_abnormal_respiratory_system | 0.72052839 |
| 120 | MP0002229_neurodegeneration | 0.67422187 |
| 121 | MP0000604_amyloidosis | 0.66284711 |
| 122 | MP0001943_abnormal_respiration | 0.65396506 |
| 123 | MP0004134_abnormal_chest_morphology | 0.65114878 |
| 124 | MP0001963_abnormal_hearing_physiology | 0.64678189 |
| 125 | MP0002234_abnormal_pharynx_morphology | 0.64079570 |
| 126 | MP0010769_abnormal_survival | 0.63481102 |
| 127 | MP0008961_abnormal_basal_metabolism | 0.63315246 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.63278280 |
| 129 | MP0002282_abnormal_trachea_morphology | 0.60999779 |
| 130 | MP0010770_preweaning_lethality | 0.60666596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.01895229 |
| 2 | Visual hallucinations (HP:0002367) | 4.56029200 |
| 3 | Febrile seizures (HP:0002373) | 4.27808061 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.15691807 |
| 5 | Absence seizures (HP:0002121) | 4.08695616 |
| 6 | Atonic seizures (HP:0010819) | 3.93071478 |
| 7 | Focal seizures (HP:0007359) | 3.90778174 |
| 8 | Papillary thyroid carcinoma (HP:0002895) | 3.66555152 |
| 9 | Pheochromocytoma (HP:0002666) | 3.59068608 |
| 10 | Neuroendocrine neoplasm (HP:0100634) | 3.39349164 |
| 11 | Dialeptic seizures (HP:0011146) | 3.37754881 |
| 12 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.33601622 |
| 13 | Muscle fiber splitting (HP:0003555) | 3.16973451 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 3.13968884 |
| 15 | Rimmed vacuoles (HP:0003805) | 2.97813865 |
| 16 | Polyphagia (HP:0002591) | 2.91863647 |
| 17 | Neurofibrillary tangles (HP:0002185) | 2.88010241 |
| 18 | Lower limb muscle weakness (HP:0007340) | 2.86838561 |
| 19 | Myokymia (HP:0002411) | 2.86491632 |
| 20 | Progressive inability to walk (HP:0002505) | 2.85836793 |
| 21 | Fetal akinesia sequence (HP:0001989) | 2.83997357 |
| 22 | Ankle clonus (HP:0011448) | 2.82788772 |
| 23 | Urinary urgency (HP:0000012) | 2.75760020 |
| 24 | Spinal canal stenosis (HP:0003416) | 2.72203143 |
| 25 | Broad-based gait (HP:0002136) | 2.60466223 |
| 26 | Amyotrophic lateral sclerosis (HP:0007354) | 2.60252753 |
| 27 | Hemiplegia (HP:0002301) | 2.55844988 |
| 28 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.55668943 |
| 29 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.55668943 |
| 30 | Blue irides (HP:0000635) | 2.55348297 |
| 31 | Abnormality of the corticospinal tract (HP:0002492) | 2.51557933 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 2.50725758 |
| 33 | Generalized tonic-clonic seizures (HP:0002069) | 2.48345135 |
| 34 | Inappropriate behavior (HP:0000719) | 2.46151245 |
| 35 | Hyperventilation (HP:0002883) | 2.45535447 |
| 36 | Truncal ataxia (HP:0002078) | 2.43888234 |
| 37 | Exercise-induced myalgia (HP:0003738) | 2.43241229 |
| 38 | Abnormality of the lower motor neuron (HP:0002366) | 2.42475239 |
| 39 | Papilledema (HP:0001085) | 2.41704388 |
| 40 | Rapidly progressive (HP:0003678) | 2.41437637 |
| 41 | Shoulder girdle muscle weakness (HP:0003547) | 2.32109108 |
| 42 | Absent speech (HP:0001344) | 2.31842890 |
| 43 | Long toe (HP:0010511) | 2.31272849 |
| 44 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.30749629 |
| 45 | Abnormality of alanine metabolism (HP:0010916) | 2.30749629 |
| 46 | Hyperalaninemia (HP:0003348) | 2.30749629 |
| 47 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.30107821 |
| 48 | Epileptiform EEG discharges (HP:0011182) | 2.25202802 |
| 49 | Poor eye contact (HP:0000817) | 2.24929509 |
| 50 | Bundle branch block (HP:0011710) | 2.23067142 |
| 51 | Disinhibition (HP:0000734) | 2.22466620 |
| 52 | Distal arthrogryposis (HP:0005684) | 2.22340929 |
| 53 | Frequent falls (HP:0002359) | 2.22110051 |
| 54 | Subaortic stenosis (HP:0001682) | 2.21560601 |
| 55 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.21560601 |
| 56 | Oligomenorrhea (HP:0000876) | 2.20904551 |
| 57 | Drooling (HP:0002307) | 2.19605652 |
| 58 | Excessive salivation (HP:0003781) | 2.19605652 |
| 59 | Thyroid carcinoma (HP:0002890) | 2.19600222 |
| 60 | Scanning speech (HP:0002168) | 2.19452985 |
| 61 | Agitation (HP:0000713) | 2.17968287 |
| 62 | Limb dystonia (HP:0002451) | 2.17285682 |
| 63 | Hemiparesis (HP:0001269) | 2.13369411 |
| 64 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.12718381 |
| 65 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.12718381 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.12080902 |
| 67 | Diplopia (HP:0000651) | 2.12080902 |
| 68 | Termporal pattern (HP:0011008) | 2.11015720 |
| 69 | Insidious onset (HP:0003587) | 2.11015720 |
| 70 | Peripheral hypomyelination (HP:0007182) | 2.10195441 |
| 71 | Supranuclear gaze palsy (HP:0000605) | 2.09712683 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.09102376 |
| 73 | Myotonia (HP:0002486) | 2.08586597 |
| 74 | Abnormal social behavior (HP:0012433) | 2.05444766 |
| 75 | Impaired social interactions (HP:0000735) | 2.05444766 |
| 76 | Ventricular fibrillation (HP:0001663) | 2.04039944 |
| 77 | Postural instability (HP:0002172) | 2.01785302 |
| 78 | Depression (HP:0000716) | 1.99921565 |
| 79 | Central scotoma (HP:0000603) | 1.99868590 |
| 80 | Severe short stature (HP:0003510) | 1.99429475 |
| 81 | Torticollis (HP:0000473) | 1.98853404 |
| 82 | Abnormality of salivation (HP:0100755) | 1.98780184 |
| 83 | Hypoplasia of the brainstem (HP:0002365) | 1.98480826 |
| 84 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.98480826 |
| 85 | EMG: neuropathic changes (HP:0003445) | 1.98390909 |
| 86 | Progressive cerebellar ataxia (HP:0002073) | 1.97036326 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.95837672 |
| 88 | Hyporeflexia of lower limbs (HP:0002600) | 1.95647213 |
| 89 | Facial diplegia (HP:0001349) | 1.95612543 |
| 90 | Hypsarrhythmia (HP:0002521) | 1.95400915 |
| 91 | Inability to walk (HP:0002540) | 1.95335903 |
| 92 | Intention tremor (HP:0002080) | 1.94433048 |
| 93 | Resting tremor (HP:0002322) | 1.94087921 |
| 94 | Action tremor (HP:0002345) | 1.92236210 |
| 95 | Limb-girdle muscle atrophy (HP:0003797) | 1.91945479 |
| 96 | Limb-girdle muscle weakness (HP:0003325) | 1.90671928 |
| 97 | Abnormality of the foot musculature (HP:0001436) | 1.90259765 |
| 98 | Exercise-induced muscle cramps (HP:0003710) | 1.90099721 |
| 99 | Enlarged kidneys (HP:0000105) | 1.89758417 |
| 100 | Spastic gait (HP:0002064) | 1.88798064 |
| 101 | Sudden death (HP:0001699) | 1.88577181 |
| 102 | Gowers sign (HP:0003391) | 1.88208875 |
| 103 | Ragged-red muscle fibers (HP:0003200) | 1.88154688 |
| 104 | Specific learning disability (HP:0001328) | 1.87503467 |
| 105 | Congenital primary aphakia (HP:0007707) | 1.87032613 |
| 106 | EMG: myopathic abnormalities (HP:0003458) | 1.86769685 |
| 107 | Sensorimotor neuropathy (HP:0007141) | 1.84955727 |
| 108 | Cortical dysplasia (HP:0002539) | 1.84657507 |
| 109 | Neuronal loss in central nervous system (HP:0002529) | 1.82258124 |
| 110 | Dysmetric saccades (HP:0000641) | 1.80055560 |
| 111 | Neoplasm of the adrenal gland (HP:0100631) | 1.79966935 |
| 112 | Abnormal EKG (HP:0003115) | 1.79897701 |
| 113 | Hepatoblastoma (HP:0002884) | 1.79526871 |
| 114 | Striae distensae (HP:0001065) | 1.79009258 |
| 115 | Neoplasm of the heart (HP:0100544) | 1.78792285 |
| 116 | Calf muscle hypertrophy (HP:0008981) | 1.78600419 |
| 117 | Abnormal hair whorl (HP:0010721) | 1.78020488 |
| 118 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.77571859 |
| 119 | Impaired vibratory sensation (HP:0002495) | 1.77304242 |
| 120 | Mutism (HP:0002300) | 1.76552494 |
| 121 | Protruding tongue (HP:0010808) | 1.76312862 |
| 122 | Ulnar deviation of the wrist (HP:0003049) | 1.75936827 |
| 123 | Poor speech (HP:0002465) | 1.75580918 |
| 124 | Steppage gait (HP:0003376) | 1.75516927 |
| 125 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75494667 |
| 126 | Asymmetric septal hypertrophy (HP:0001670) | 1.74645364 |
| 127 | Difficulty climbing stairs (HP:0003551) | 1.74625619 |
| 128 | Abnormality of the calf musculature (HP:0001430) | 1.74245220 |
| 129 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72435713 |
| 130 | Hypoplasia of the corpus callosum (HP:0002079) | 1.72106221 |
| 131 | Muscle fiber inclusion bodies (HP:0100299) | 1.70819183 |
| 132 | Increased variability in muscle fiber diameter (HP:0003557) | 1.69788950 |
| 133 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.69354178 |
| 134 | Labial hypoplasia (HP:0000066) | 1.69335468 |
| 135 | Hypothermia (HP:0002045) | 1.68899297 |
| 136 | Clonus (HP:0002169) | 1.68285684 |
| 137 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.68007774 |
| 138 | Dysmetria (HP:0001310) | 1.66492128 |
| 139 | Apathy (HP:0000741) | 1.66443639 |
| 140 | Impaired smooth pursuit (HP:0007772) | 1.66286348 |
| 141 | Round ear (HP:0100830) | 1.65729705 |
| 142 | Foot dorsiflexor weakness (HP:0009027) | 1.65494042 |
| 143 | Anxiety (HP:0000739) | 1.65031115 |
| 144 | Focal dystonia (HP:0004373) | 1.64907237 |
| 145 | Hamartoma of the eye (HP:0010568) | 1.64794953 |
| 146 | Intellectual disability, profound (HP:0002187) | 1.63128488 |
| 147 | Pelvic girdle muscle weakness (HP:0003749) | 1.63036883 |
| 148 | Gait imbalance (HP:0002141) | 1.62204289 |
| 149 | Genetic anticipation (HP:0003743) | 1.62004660 |
| 150 | Abnormal eating behavior (HP:0100738) | 1.61761508 |
| 151 | Exotropia (HP:0000577) | 1.60366973 |
| 152 | Volvulus (HP:0002580) | 1.59725273 |
| 153 | Nemaline bodies (HP:0003798) | 1.57962489 |
| 154 | Incomplete penetrance (HP:0003829) | 1.57146400 |
| 155 | Amblyopia (HP:0000646) | 1.56635323 |
| 156 | Complete atrioventricular canal defect (HP:0001674) | 1.56243602 |
| 157 | Generalized hypopigmentation of hair (HP:0011358) | 1.55386815 |
| 158 | Difficulty running (HP:0009046) | 1.53964213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K4 | 3.01287604 |
| 2 | MARK1 | 2.86639608 |
| 3 | MAP3K12 | 2.85869823 |
| 4 | OBSCN | 2.73519415 |
| 5 | MAP2K7 | 2.71238323 |
| 6 | FGFR2 | 2.70672066 |
| 7 | NTRK2 | 2.54146421 |
| 8 | NTRK3 | 2.46289291 |
| 9 | MINK1 | 2.35447179 |
| 10 | PDK3 | 2.33139074 |
| 11 | PDK4 | 2.33139074 |
| 12 | SIK2 | 1.98135618 |
| 13 | CDK19 | 1.97360007 |
| 14 | MUSK | 1.93804392 |
| 15 | PRPF4B | 1.93555518 |
| 16 | ERBB3 | 1.91987582 |
| 17 | MAP2K4 | 1.90813368 |
| 18 | CASK | 1.89349528 |
| 19 | KSR1 | 1.84322080 |
| 20 | FGFR3 | 1.78609638 |
| 21 | SGK2 | 1.76133301 |
| 22 | TRIB3 | 1.74947023 |
| 23 | MAPK13 | 1.61448776 |
| 24 | DAPK2 | 1.58202043 |
| 25 | PDGFRA | 1.55574495 |
| 26 | SIK3 | 1.53693258 |
| 27 | MAP3K9 | 1.49912750 |
| 28 | SGK3 | 1.48173931 |
| 29 | PLK2 | 1.40773913 |
| 30 | SGK223 | 1.39025031 |
| 31 | SGK494 | 1.39025031 |
| 32 | TYRO3 | 1.38083587 |
| 33 | RET | 1.36556845 |
| 34 | FGFR4 | 1.35148328 |
| 35 | DYRK3 | 1.30703462 |
| 36 | EPHA4 | 1.28766398 |
| 37 | MAP4K2 | 1.21023542 |
| 38 | CCNB1 | 1.20333736 |
| 39 | FGR | 1.17072241 |
| 40 | DYRK1A | 1.14968785 |
| 41 | PRKCH | 1.14632227 |
| 42 | CAMKK2 | 1.12747080 |
| 43 | IRAK2 | 1.07504531 |
| 44 | CAMKK1 | 1.03606403 |
| 45 | LATS2 | 1.02417055 |
| 46 | PTK2B | 1.01407002 |
| 47 | TTN | 0.98853640 |
| 48 | NEK9 | 0.98796652 |
| 49 | PAK6 | 0.96573808 |
| 50 | DAPK1 | 0.96442436 |
| 51 | EPHB1 | 0.94142389 |
| 52 | GRK7 | 0.93169088 |
| 53 | BLK | 0.91963458 |
| 54 | RPS6KA4 | 0.91521571 |
| 55 | ITK | 0.89152855 |
| 56 | PKN2 | 0.86718926 |
| 57 | PHKG1 | 0.86051745 |
| 58 | PHKG2 | 0.86051745 |
| 59 | MAP3K13 | 0.85094897 |
| 60 | KSR2 | 0.84834538 |
| 61 | PDGFRB | 0.84247659 |
| 62 | CDK5 | 0.83530096 |
| 63 | PDK2 | 0.83150057 |
| 64 | NTRK1 | 0.82709941 |
| 65 | DYRK2 | 0.80969397 |
| 66 | LMTK2 | 0.80631133 |
| 67 | BCR | 0.79629892 |
| 68 | EEF2K | 0.78899998 |
| 69 | RIPK4 | 0.78143030 |
| 70 | CSNK1A1L | 0.75340148 |
| 71 | LATS1 | 0.73484784 |
| 72 | EPHA3 | 0.73483466 |
| 73 | WNK3 | 0.71995917 |
| 74 | FGFR1 | 0.71952135 |
| 75 | MAP3K5 | 0.71875823 |
| 76 | MAP3K7 | 0.71062441 |
| 77 | TSSK6 | 0.69184779 |
| 78 | STK11 | 0.68819952 |
| 79 | CSNK1G3 | 0.68731063 |
| 80 | PDK1 | 0.67722888 |
| 81 | UHMK1 | 0.67602899 |
| 82 | MAP3K6 | 0.67440155 |
| 83 | TAOK1 | 0.67355278 |
| 84 | PINK1 | 0.66298541 |
| 85 | AKT3 | 0.65334610 |
| 86 | PRKCE | 0.65023092 |
| 87 | CSNK1G2 | 0.64933827 |
| 88 | JAK2 | 0.63678371 |
| 89 | STK24 | 0.63655362 |
| 90 | PAK3 | 0.63635575 |
| 91 | EPHB2 | 0.63550337 |
| 92 | PRKCZ | 0.62814928 |
| 93 | ROCK1 | 0.60982095 |
| 94 | CAMK4 | 0.59001491 |
| 95 | DYRK1B | 0.58920941 |
| 96 | CAMK2A | 0.58349089 |
| 97 | TXK | 0.58155880 |
| 98 | YES1 | 0.58063558 |
| 99 | MOS | 0.58036966 |
| 100 | TIE1 | 0.57888891 |
| 101 | DDR2 | 0.57793085 |
| 102 | CAMK2B | 0.56996851 |
| 103 | CAMK2G | 0.56651745 |
| 104 | DMPK | 0.54689836 |
| 105 | RAF1 | 0.54504287 |
| 106 | FYN | 0.54076298 |
| 107 | SGK1 | 0.54063242 |
| 108 | NEK1 | 0.53190586 |
| 109 | ACVR1B | 0.52083051 |
| 110 | MAP3K10 | 0.50834339 |
| 111 | RPS6KA2 | 0.50488615 |
| 112 | CSNK1G1 | 0.50329047 |
| 113 | MAPK12 | 0.49040227 |
| 114 | RIPK1 | 0.48234953 |
| 115 | BRAF | 0.46762324 |
| 116 | PKN1 | 0.44039545 |
| 117 | PRKD1 | 0.43963015 |
| 118 | MARK2 | 0.42537523 |
| 119 | PNCK | 0.41908182 |
| 120 | SRPK1 | 0.41677053 |
| 121 | PRKG1 | 0.41329502 |
| 122 | CDK14 | 0.41299341 |
| 123 | GRK5 | 0.41182054 |
| 124 | CAMK1G | 0.40772056 |
| 125 | PRKCG | 0.40559932 |
| 126 | PRKAA1 | 0.40450842 |
| 127 | CAMK2D | 0.38835173 |
| 128 | ADRBK2 | 0.37525303 |
| 129 | PRKD3 | 0.37515709 |
| 130 | ARAF | 0.37410406 |
| 131 | PDPK1 | 0.36937283 |
| 132 | CSK | 0.36687728 |
| 133 | CDK18 | 0.36521467 |
| 134 | FES | 0.35585920 |
| 135 | LIMK1 | 0.35154421 |
| 136 | CAMK1 | 0.34771944 |
| 137 | MAPK10 | 0.34497423 |
| 138 | ILK | 0.34276738 |
| 139 | MAPK7 | 0.33350010 |
| 140 | ERBB4 | 0.31509639 |
| 141 | JAK1 | 0.30946638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.13097599 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.47986100 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.37665341 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.37530906 |
| 5 | Circadian rhythm_Homo sapiens_hsa04710 | 2.30026109 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.01879596 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92776842 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.86776941 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.86726274 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 1.82380463 |
| 11 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.74958254 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.66122504 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.63583693 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.62677766 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.55730793 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55549666 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.52197499 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.49505496 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.47522017 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.43454917 |
| 21 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.37130981 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.36425266 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.26993368 |
| 24 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.26424232 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25916891 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.25549889 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.24744426 |
| 28 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17782626 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.17526202 |
| 30 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.15956454 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15217416 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13624741 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12590623 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.11704933 |
| 35 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.11498839 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11320575 |
| 37 | Colorectal cancer_Homo sapiens_hsa05210 | 1.10035454 |
| 38 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.08842951 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.08115803 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06257044 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06168888 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04883475 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.04814829 |
| 44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.03953586 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03080080 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 1.02154646 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.01512170 |
| 48 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.00128747 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99777661 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98995638 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98275725 |
| 52 | Glioma_Homo sapiens_hsa05214 | 0.94313670 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 0.94102738 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94062868 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91721049 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91366112 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.90094906 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88333680 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85116623 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 0.85100970 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84767653 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84676282 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84061021 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83536073 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83283987 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83122598 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81617128 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81347214 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81203793 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79131501 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78161274 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78012461 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77946459 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.77399841 |
| 75 | Gap junction_Homo sapiens_hsa04540 | 0.77302158 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76495371 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76148436 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75874222 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75641308 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72916663 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72654800 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.71685751 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70066673 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69915635 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68806921 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67468474 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.67369259 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66883495 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64361952 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.63982853 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59300891 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59197346 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.58620808 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.57322472 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57285090 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56417002 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56175711 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55389763 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54493097 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53502737 |
| 101 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53451056 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.52713809 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.52638990 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51405639 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51292950 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50725889 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49966259 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | 0.49223780 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48390975 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47866054 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47557856 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47212639 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46755360 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46720048 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.46201862 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44805379 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44429829 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44113735 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42493548 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.42134649 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41875098 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.41746254 |
| 123 | Lysosome_Homo sapiens_hsa04142 | 0.41211782 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40163588 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38662638 |

